Nanoparticles for Chemoimmunotherapy Against Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) exhibits high recurrence and mortality rates because of the lack of effective treatment targets. Surgery and traditional chemotherapy are the primary treatment options. Immunotherapy shows high potential for treating various cancers but exhibits limited efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Siyan, Li, Jing, Gu, Lin, Wu, Kunzhe, Xing, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651025/
https://www.ncbi.nlm.nih.gov/pubmed/36388877
http://dx.doi.org/10.2147/IJN.S388075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651025/
https://www.ncbi.nlm.nih.gov/pubmed/36388877
http://dx.doi.org/10.2147/IJN.S388075

Ejemplares similares